Phthalazinones

Details Phthalazinones Phthalazinones

2007-03-06

2007-03-06

Tucker, Zachary C. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S234500, C514S248000, C540S599000, C544S116000, C544S119000, C544S237000

Reexamination Certificate

active

10475657

ABSTRACT:
The compounds of formula Iin which R1, R2, R3, R4 and R5 have the meanings as given in the description are PDE4/7 inhibitors.

REFERENCES:
patent: 5716954 (1998-02-01), Wilhelm et al.
patent: 5859008 (1999-01-01), Jonas et al.
patent: 6103718 (2000-08-01), Sterk
patent: 6255303 (2001-07-01), Sterk
patent: 6380196 (2002-04-01), Ulrich et al.
patent: 6544993 (2003-04-01), Sterk
patent: 0763534 (1996-09-01), None
patent: 0934933 (1999-08-01), None
patent: WO 93/07146 (1993-04-01), None
patent: WO 94/12461 (1994-06-01), None
patent: WO 98/31674 (1998-07-01), None
patent: WO 99/31071 (1999-06-01), None
patent: WO 99/31090 (1999-06-01), None
patent: WO99/47505 (1999-09-01), None
patent: WO 01/19818 (2001-03-01), None
patent: WO 01/30766 (2001-05-01), None
patent: WO 01/30777 (2001-05-01), None
patent: WO 01/94319 (2001-12-01), None
Huang et al, “The Next Generation of PDE4 Inhibitors” Current Opinion in Chemical Biology, vol. 5, pp. 432-438 (2001).
Dyke and Montana “The therapeutic potential of PDE4 inhibitors” Expert Opinion on Investigational Drugs, vol. 8(9), pp. 1301-1325 (1999).
Van der Mey, et al., “Novel Selective PDE4 Inhibitors. 1. Synthesis, Structure—Activity Relationships, and Molecular Modeling of 4-(3,4-dimethoxyphenyl)-2H phthalazin-1-ones and Analogues”, J. Med. Chem., 44, p. 2511-2522 (2001).
Van der Mey, et al., “Novel Selective PDE4 Inhibitors. 2. Synthesis and Structure—Activity Relationships of 4-Aryl-Substituted cis-tetra and cis-Hexahydrophthalazinones”, J. Med. Chem., 44, p. 2523-2535 (2001).
Van der Mey, et al., “Novel Selective PDE4 Inhibitors. 3. In vivo Antiinflammatory Activity of a New Series of N-Substituted cis-Tetra and cis-Hexahydrophthalazinones”, J. Med. Chem., 45, p. 2520-2525 (2002).
Van der Mey, et al., “Novel Selective Phosphodiesterase (PDE4) Inhibitors. 4. Resolution, Absolute Configuration and PDE4 Inhibitory Activity of cis-Tetra and cis-Hexahydrophthalazinones”, J. Med. Chem., 45, p. 2526-2533 (2002).
Dal Piaz V., et al. “Novel Heterocyclic Fused Pyridazinones as Potent and Selective Phosphodiesterase IV Inhibitors”, J. Med. Chem., 40, p. 1417-1421 (1997).
Thornber, C.W., “Isosterism and Molecular Modification in Drug Design”, Chem. Soc. Reviews, pp. 563-579 (1979).

Affiliated with

Also associated with

Rating

Phthalazinones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phthalazinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phthalazinones will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3741410